A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients
Published in
Biology of Blood & Marrow Transplantation, December 2013
Pharmacology, Toxicology and Pharmaceutical Science
4
10%
Agricultural and Biological Sciences
2
5%
Chemical Engineering
1
3%
Nursing and Health Professions
1
3%
Other
3
8%
Unknown
12
31%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2017.
All research outputs
#10,795,106
of 34,559,526 outputs
Outputs from Biology of Blood & Marrow Transplantation
#1,695
of 3,753 outputs
Outputs of similar age
#106,176
of 378,330 outputs
Outputs of similar age from Biology of Blood & Marrow Transplantation
#29
of 56 outputs
Altmetric has tracked 34,559,526 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 3,753 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 378,330 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
